CS Diagnostics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2009	FY 2008
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008
Operating Revenue	-	0.11	0.13	-	-
Other Revenue	0.2	-	-	-	-
Revenue	0.2	0.11	0.13	-	-
Revenue Growth (YoY)	83.93%	-12.00%	-	-	-
Gross Profit	0.2	0.11	0.13	-	-
Selling, General & Admin	0.13	0.11	0.15	0.23	0.36
Operating Expenses	0.13	0.11	0.15	0.23	0.36
Operating Income	0.07	0	-0.02	-0.23	-0.36
Other Non Operating Income (Expenses)	-	-	-	-0.04	-0.05
Pretax Income	0.07	0	-0.02	-0.27	-0.4
Net Income	0.07	0	-0.02	-0.27	-0.4
Net Income to Common	0.07	0	-0.02	-0.27	-0.4
Net Income Growth	9258.61%	-	-	-	-
Shares Outstanding (Basic)	250	137	111	0	0
Shares Outstanding (Diluted)	250	137	111	0	0
Shares Change (YoY)	82.09%	23.92%	114621.71%	-	-
EPS (Basic)	0.00	0.00	-0.00	-2.79	-4.16
EPS (Diluted)	0.00	0.00	-0.00	-2.79	-4.16
EPS Growth	5580.00%	-	-	-	-
Free Cash Flow	0.01	0.01	0.01	-0	-0.74
Free Cash Flow Per Share	-	-	-	-0.00	-7.69
Gross Margin	100.00%	100.00%	100.00%	-	-
Operating Margin	34.91%	0.69%	-17.45%	-	-
Profit Margin	34.91%	0.69%	-17.45%	-	-
Free Cash Flow Margin	3.09%	9.95%	7.37%	-	-
EBITDA	-	-	-	-0.23	-0.35
D&A For EBITDA	-	-	-	0	0
EBIT	0.07	0	-0.02	-0.23	-0.36
EBIT Margin	34.91%	0.69%	-17.45%	-	-
Revenue as Reported	0.2	0.11	0.13	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.